Sana Biotechnology, Inc. (SANA)
3.16
+0.05
(+1.61%)
USD |
NASDAQ |
May 21, 16:00
3.16
0.00 (0.00%)
After-Hours: 18:27
Sana Biotechnology Total Liabilities (Quarterly) : 254.35M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ImmunityBio, Inc. | 1.516B |
| Vertex Pharmaceuticals, Inc. | 7.122B |
| Sarepta Therapeutics, Inc. | 1.674B |
| Beam Therapeutics, Inc. | 316.36M |
| Prelude Therapeutics, Inc. | 59.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 373.59M |
| Shareholders Equity (Quarterly) | 119.24M |
| Debt to Equity Ratio | 0.6317 |
| Current Ratio | 1.295 |
| Net Debt Paydown Yield | 0.49% |